Intuitive Surgical (NASDAQ:ISRG) Director Gary Guthart Sells 20,095 Shares of Stock

Key Points

• Director Gary Guthart sold 20,095 Intuitive Surgical shares for approximately $9.1 million at an average price of $451.61 under a pre-arranged Rule 10b5-1 plan, reducing his position by 1.64%.
• Intuitive Surgical reported strong quarterly results, with EPS of $3.00 and revenue of $3.05 billion, exceeding analyst estimates and representing 21.7% year-over-year revenue growth.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $493.54; institutional investors own 83.64% of the company.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Gary Guthart sold 20,095 shares of the business's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $1.61 during trading hours on Monday, reaching $450.68. 1,788,902 shares of the stock were exchanged, compared to its average volume of 2,427,984. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock has a market cap of $156.22 billion, a P/E ratio of 54.42, a P/E/G ratio of 3.12 and a beta of 1.46. The firm's 50 day moving average is $395.50 and its 200 day moving average is $408.83.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business's revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.40 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently added to or reduced their stakes in the business. Plato Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the second quarter valued at $4,315,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Intuitive Surgical in the 2nd quarter valued at about $14,316,000. Hikari Power Ltd acquired a new position in Intuitive Surgical in the 2nd quarter valued at about $5,619,000. NewEdge Advisors LLC lifted its holdings in Intuitive Surgical by 19.1% in the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider's stock valued at $20,212,000 after purchasing an additional 8,142 shares in the last quarter. Finally, Nykredit A S acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $48,464,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $450.00 to $475.00 and gave the company an "overweight" rating in a report on Wednesday, October 21st. BNP Paribas Exane upgraded shares of Intuitive Surgical to an "outperform" rating in a research report on Tuesday, July 28th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Wells Fargo & Company reiterated an "overweight" rating and issued a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, KeyCorp reiterated an "overweight" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.